Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2015 to Q4 2025

Type / Class
Equity / Class A Common Stock, par value $0.01 per share
Symbol
EVH on NYSE
Shares outstanding
112,318,617
Price per share
$3.94
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
120,369,018
Total reported value
$481,484,405
% of total 13F portfolios
0%
Share change
-15,045,104
Value change
-$146,762,693
Number of holders
208
Price from insider filings
$3.94
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CADIAN CAPITAL MANAGEMENT, LP 9.3% $106,218,923 10,794,606 Cadian Capital Management, LP 31 Mar 2025
MORGAN STANLEY 8.1% +16% $37,755,903 +$3,682,702 9,097,808 +11% Morgan Stanley 31 Dec 2025
VANGUARD GROUP INC 8% $35,656,260 8,914,065 The Vanguard Group 31 Dec 2025
Boehler Adam 5.2% $49,204,401 5,816,123 Rubicon OP GP II LP 13 Nov 2025
RA CAPITAL MANAGEMENT, L.P. 3.1% $35,199,618 3,577,197 RA Capital Management, L.P. 31 Dec 2024
FMR LLC 0.7% -91% $3,003,548 -$34,663,704 750,887 -92% FMR LLC 31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP 0.4% -96% $5,016,947 -$113,228,542 442,802 -96% Wellington Management Group LLP 30 Jun 2025
EVENTIDE ASSET MANAGEMENT, LLC 0% -108% $7,109 -$26,106,812 1,713 -100% Eventide Asset Management, LLC 31 Dec 2025

As of 31 Dec 2025, 208 institutional investors reported holding 120,369,018 shares of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH). This represents 107% of the company’s total 112,318,617 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) together control 87% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
CADIAN CAPITAL MANAGEMENT, LP 9.9% 11,085,455 -5.5% 3.2% $44,341,820
BlackRock, Inc. 9.2% 10,331,551 +11% 0% $41,326,204
MORGAN STANLEY 8.3% 9,278,123 +16% 0% $37,112,494
VANGUARD GROUP INC 7.9% 8,914,065 -19% 0% $35,656,260
UBS Group AG 5.4% 6,109,618 +80% 0% $24,438,472
Rubicon Founders LLC 5.2% 5,816,123 0% 15% $23,264,492
Engaged Capital LLC 5% 5,563,912 -1.8% 5.7% $22,255,648
D. E. Shaw & Co., Inc. 4.7% 5,269,302 +92% 0.02% $21,077,208
JANE STREET GROUP, LLC 2.6% 2,952,947 +105% 0.01% $11,811,788
JPMORGAN CHASE & CO 2.6% 2,947,686 -26% 0% $11,790,744
STATE STREET CORP 2.6% 2,941,761 -1.1% 0% $11,767,044
GEODE CAPITAL MANAGEMENT, LLC 2.4% 2,733,444 -0.86% 0% $10,935,890
Rock Springs Capital Management LP 2.4% 2,675,000 -9.3% 0.55% $10,700,000
MAVERICK CAPITAL LTD 2.3% 2,539,930 +6% 0.11% $10,159,720
DIMENSIONAL FUND ADVISORS LP 2.1% 2,307,784 -8% 0% $9,231,434
JACOBS LEVY EQUITY MANAGEMENT, INC 2% 2,268,872 +28% 0.04% $9,075,488
CITADEL ADVISORS LLC 1.7% 1,855,017 -19% 0.01% $7,420,068
GOLDMAN SACHS GROUP INC 1.6% 1,833,495 +108% 0% $7,333,980
TWO SIGMA INVESTMENTS, LP 1.4% 1,537,524 +81% 0.01% $6,150,096
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.3% 1,516,215 +16% 0% $6,064,860
MILLENNIUM MANAGEMENT LLC 1.3% 1,475,042 +223% 0% $5,900,168
Hudson Bay Capital Management LP 1.3% 1,460,000 +153% 0.03% $5,840,000
Tejara Capital Ltd 1.2% 1,331,441 2.2% $5,325,764
Balyasny Asset Management L.P. 1.1% 1,261,007 +622% 0.01% $5,044,028
Rock Point Advisors, LLC 1.1% 1,190,156 +22% 1.2% $4,760,624

Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 120,369,018 $481,484,405 -$146,762,693 $4.00 208
2025 Q3 135,659,696 $1,147,817,881 +$12,305,118 $8.46 237
2025 Q2 131,673,312 $1,482,570,130 +$78,519,495 $11.26 218
2025 Q1 125,716,823 $1,190,564,177 +$20,137,898 $9.47 222
2024 Q4 122,283,963 $1,375,271,472 -$248,054,960 $11.25 237
2024 Q3 129,270,440 $3,653,744,995 +$36,997,360 $28.28 255
2024 Q2 129,502,142 $2,475,760,428 +$40,167,326 $19.12 239
2024 Q1 125,850,762 $4,125,692,137 -$4,762,881 $32.79 247
2023 Q4 126,464,041 $4,176,843,783 +$156,108,720 $33.03 232
2023 Q3 122,189,782 $3,342,247,641 +$125,298,418 $27.23 201
2023 Q2 117,663,348 $3,553,501,314 +$168,830,769 $30.30 216
2023 Q1 111,825,275 $3,615,108,333 +$350,007,462 $32.45 237
2022 Q4 101,432,734 $2,846,879,147 +$146,714,497 $28.08 229
2022 Q3 95,515,991 $3,431,522,864 +$214,834,478 $35.93 243
2022 Q2 89,722,827 $2,755,609,040 +$99,219,171 $30.71 207
2022 Q1 86,524,226 $2,793,511,290 +$66,700,981 $32.30 208
2021 Q4 84,687,344 $2,342,026,098 -$26,236,636 $27.67 200
2021 Q3 85,614,905 $2,649,865,771 +$83,228,566 $31.00 205
2021 Q2 83,046,124 $1,753,120,165 +$24,126,478 $21.12 175
2021 Q1 81,962,439 $1,657,194,786 +$54,461,956 $20.20 163
2020 Q4 81,531,166 $1,307,117,041 +$30,502,553 $16.03 153
2020 Q3 79,968,182 $996,864,007 +$91,919,009 $12.41 147
2020 Q2 73,419,664 $521,944,449 -$8,509,221 $7.12 127
2020 Q1 76,262,366 $412,459,741 -$45,659,323 $5.43 144
2019 Q4 84,391,629 $763,718,223 +$19,537,960 $9.05 160
2019 Q3 83,189,885 $598,108,319 +$36,446,789 $7.19 164
2019 Q2 79,612,606 $632,474,946 -$65,435,843 $7.95 176
2019 Q1 80,054,942 $1,007,122,936 -$87,346,992 $12.58 181
2018 Q4 84,343,531 $1,681,537,423 -$4,941,229 $19.95 179
2018 Q3 83,480,362 $2,370,707,599 +$83,198,140 $28.40 184
2018 Q2 81,349,096 $1,712,497,871 +$62,476,305 $21.05 175
2018 Q1 79,341,302 $1,130,145,805 +$51,206,773 $14.25 145
2017 Q4 77,238,335 $950,283,643 -$27,787,288 $12.30 151
2017 Q3 73,756,624 $1,317,768,623 +$165,302,431 $17.80 161
2017 Q2 61,976,434 $1,571,057,213 +$516,654,926 $25.35 163
2017 Q1 41,564,536 $920,662,382 +$288,907,012 $22.30 131
2016 Q4 29,423,943 $435,469,686 -$1,463,761 $14.80 116
2016 Q3 27,318,932 $672,581,312 +$205,110,750 $24.62 109
2016 Q2 17,955,627 $344,747,539 +$34,816,467 $19.20 77
2016 Q1 16,464,327 $173,856,000 +$3,040,299 $10.56 69
2015 Q4 16,088,789 $194,836,902 +$1,686,845 $12.11 67
2015 Q3 15,782,348 $251,887,856 +$9,524,041 $15.96 69
2015 Q2 14,783,450 $288,279,132 +$288,279,132 $19.50 62